Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
BM |
|
G
|
Geo Energy Resources Ltd
OTC:GRYRF
|
SG |
|
F3 Uranium Corp
OTC:FUUFF
|
CA |
Wall St Price Targets
KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for KNSA is 63.53 USD with a low forecast of 57.57 USD and a high forecast of 74.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KNSA's stock price target?
Price Target
63.53
USD
According to Wall Street analysts, the average 1-year price target for KNSA is 63.53 USD with a low forecast of 57.57 USD and a high forecast of 74.55 USD.
What is the Revenue forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
24%
The compound annual growth rate for Revenue over the next 3 years is 24%.
What is the Gross Profit forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 3 years is 24%.
What is the Operating Income forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
47%
The compound annual growth rate for Operating Income over the next 3 years is 47%.
What is the Pre-Tax Income forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
51%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 51%.
What is the Net Income forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
54%
The compound annual growth rate for Net Income over the next 3 years is 54%.
